Closes today at 17:00
IT & software · London Upcoming
PME for Tissue and Cell Management System
King's College Hospital NHS Foundation Trust · Expected to open January 2027
What this tender is
King's College Hospital NHS Foundation Trust is seeking suppliers for “PME for Tissue and Cell Management System”. It is classed as it & software services, with delivery in London.
In the buyer's own words: King's College Hospital NHS Foundation Trust ("the Trust") is carrying out preliminary market engagement under the Procurement Act 2023 to understand the solutions available for a tissue and cell management system supporting its stem cell transplantation and cellular therapy laboratory services. The Trust currently uses a commercial off-the-shelf tissue and cell management system, in live use since 2023. The infrastructure on which it runs reaches end of support in January 2027, and the Trust is assessing its options for continuity of service from 2027. These include upgrading or migrating…
The procedure and any lots are set out in full on the official notice.
The estimated value is £375k, as stated by the buyer; the final value can differ.
Ktenders places each notice in a trade from the classification code the buyer chose and in a region from the delivery location it gives, so if the scope looks different from the trade shown here, the official notice is the one to trust.
Who it suits
This tender is most relevant to it & software suppliers able to deliver in London.
At this size buyers usually expect evidence of similar work, appropriate insurance and stable finances, so smaller firms often bid as part of a consortium or as a subcontractor.
Public buyers in the UK must treat suppliers equally and explain how bids will be scored, so the selection and award criteria in the tender documents are the best guide to whether this opportunity is worth your time.
Before deciding to bid, read the full notice and any attached documents: they set out the exact requirements, selection criteria and how bids will be scored.
Key dates
The notice was published on 11 November 2026.
This is a pipeline notice: the buyer intends to run a procurement and expects it to open around January 2027. No bids can be submitted yet.
Pipeline notices give suppliers time to prepare. Many invite early market engagement — a questionnaire, a supplier day or a request for information — and taking part helps the buyer shape a tender that suits firms like yours. When the buyer publishes the full tender notice, it will appear on Ktenders with its closing date.
Dates in pipeline notices are estimates and often move, so register on the buyer's portal and check the official notice for updates rather than relying on the expected month alone.
Original notice text
King's College Hospital NHS Foundation Trust ("the Trust") is carrying out preliminary market engagement under the Procurement Act 2023 to understand the solutions available for a tissue and cell management system supporting its stem cell transplantation and cellular therapy laboratory services.
The Trust currently uses a commercial off-the-shelf tissue and cell management system, in live use since 2023. The infrastructure on which it runs reaches end of support in January 2027, and the Trust is assessing its options for continuity of service from 2027. These include upgrading or migrating the existing solution and adopting an alternative solution. The purpose of this engagement is to establish which providers of this type of system exist in the market, and their level of interest, to help the Trust decide on the most appropriate route to market and timescales. The outcome will inform the Trust's requirements, options appraisal and business case, and the Trust anticipates that it will be followed by a formal procurement.
The Trust is seeking solutions that provide end-to-end management and traceability of cellular therapy products, from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. The solution will need to support:
• labelling and traceability in line with ICCBBA ISBT 128 standards;
• a complete and secure audit trail;
• quality management, including deviations and non-conformances;
• inventory and storage location management; and
• reporting.
The solution will need to enable the service to meet Human Tissue Authority (HTA) licensing requirements and FACT-JACIE accreditation standards. It should also meet electronic record and traceability requirements under GAMP 5, GMP Annex 11 (Computerised Systems) and 21 CFR Part 11, and comply with MHRA data integrity expectations. Supplier support for installation, operational and performance qualification (IQ/OQ/PQ) will be required before go-live, together with an approach to upgrades after go-live that controls system changes and minimises the revalidation burden.
The Trust is particularly interested in understanding the following:
• which suppliers offer a solution that can meet these requirements, and any areas that would not be met;
• deployment models (on-premise, supplier-hosted or cloud/SaaS), including whether solutions can be delivered on Microsoft-based infrastructure (Windows Server and Microsoft SQL Server) or as a fully hosted service;
• whether suppliers have live interfaces with Epic or other electronic patient record systems in the UK;
• typical implementation timescales, including validation and data migration;
• indicative costs, to help inform the Trust's Outline Business Case;
• whether the solution is available through an NHS England-approved framework agreement or dynamic market; and
• whether suppliers would expect to take part in a competitive procurement, and their views on the Trust's proposed approach and indicative timescales.
More it & software tenders
3 days left
4 days left
4 days left
4 days left
5 days left
More tenders in London
3 days left
3 days left
3 days left
3 days left
3 days left
3 days left
Closing soon
Closes today at 12:00
Closes tomorrow at 12:00
Closes tomorrow at 16:00
Closes tomorrow at 23:59
2 days left
3 days left